TLX News: Health Canada Approves Illuccix® for Prostate Cancer Imaging - 14th Oct 2022, 11:21am

[annb0t]

MELBOURNE, Australia, Oct. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that Health Canada has approved Illuccix® [kit for the preparation of gallium (68Ga) gozetotide injection] for use in staging and re-staging intermediate and high-risk prostate cancer and localizing tumour tissue in recurrent prostate cancer. (PRNewsfoto/Telix Pharmaceuticals Limited)

Illuccix™ [kit for the preparation of gallium (68Ga) gozetotide injection], ...

>>> Read more: Health Canada Approves Illuccix® for Prostate Cancer Imaging